Healthcare IT Today February 25, 2025
Quibim, a healthtech company focused on the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing.
The company said it has experienced growth in the number of patients analyzed by its products over the past year. Driven by several regulatory approvals and global commercial partnerships, patient analysis surged by 168% quarter-on-quarter. The financing was led by Asabys (through its fund Sabadell Asabys II) and Buenavista Equity Partners (through the BHG I fund, created in partnership with Columbus Venture Partners), and joined by UI Investissements, and GoHub Ventures as new investors. It was also joined by current investors, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind (KFund’s early growth fund), Tony...
Today's Sponsors
Today's Sponsor